Skip to content
Screener

SG&A at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$6.43B+9.2%
AbbVie logo
AbbVieABBV
$3.63B+11.7%
IAR
Integra LifeSciencesIART
$172.44M-4.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$138.03M+1.1%
MiMedx Group logo
MiMedx GroupMDXG
$59.78M-6.8%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$22.6M+15.1%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of revenue19,83116,02837,37329,597
Gross profit47,71135,27290,04663,080
Operating expenses:
Sales, general and administrative46,90544,17690,51083,875
Research and development5,0965,20310,33710,258
Total operating expenses52,00149,379100,84794,133
Loss from operations(4,290)(14,107)(10,801)(31,053)
Interest income369162341

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's SG&A?
Establishment Labs (ESTA) reported SG&A of $46.91M in Q2 2026.
How has Establishment Labs's SG&A changed year-over-year?
Establishment Labs's SG&A increased by 6.2% year-over-year, from $44.18M to $46.91M.
What is the long-term trend for Establishment Labs's SG&A?
Over 4 years (2021 to 2025), Establishment Labs's SG&A has grown at a 15.7% compound annual growth rate (CAGR), from $92.23M to $165.07M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Ask your AI about Establishment Labs's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude